Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam on postoperative QT interval in gynecologic laparotomy
jRCT1051220068Active, not recruiting
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms). Primary endpoint: Heart-rate corrected QT interval after tracheal extubation. Started Sep 2022; status: active, not recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT1051220068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220068.